Provided by Tiger Fintech (Singapore) Pte. Ltd.

Altimmune, Inc.

5.03
-0.4000-7.37%
Post-market: 5.100.0700+1.39%19:59 EDT
Volume:2.90M
Turnover:14.83M
Market Cap:387.38M
PE:-3.76
High:5.37
Open:5.36
Low:4.95
Close:5.43
Loading ...

Coinbase Adds ALT, PENDLE, and L3 to Asset Listing Roadmap

Blockbeats
·
21 Mar

Press Release: MetaVia Reports Year End 2024 Financial Results and Provides Corporate Update

Dow Jones
·
20 Mar

Altimmune Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Mar

Altimmune call volume above normal and directionally bullish

TIPRANKS
·
15 Mar

Altimmune Price Target Maintained With a $25.00/Share by Citizens Capital Markets

Dow Jones
·
14 Mar

Altimmune Shares up 4.5% on Plans to Test Obesity Drug for Alcohol Use Disorder, Other Conditions

THOMSON REUTERS
·
14 Mar

BRIEF-Altimmune Inc Phase 2 AUD Trial For Pemvidutide Expected In Q2 2025

Reuters
·
14 Mar

BUZZ-Altimmune gains on plans to test weight-loss drug for alcohol use disorder, other conditions

Reuters
·
14 Mar

Altimmune Inc - Phase 2 AUD Trial for Pemvidutide Expected in Q2 2025

THOMSON REUTERS
·
14 Mar

ALT Resources PLC Publishes Annual Report for 2024

TIPRANKS
·
11 Mar

Lilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study

PR Newswire
·
09 Mar

Altimmune (ALT) Initiated with a Hold at William Blair

TIPRANKS
·
06 Mar

Altimmune Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Mar

William Blair Initiates Altimmune at Market Perform

MT Newswires Live
·
28 Feb

Altimmune Initiated at Market Perform by William Blair

Dow Jones
·
28 Feb

Altimmune Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St.
·
28 Feb

U.S. RESEARCH ROUNDUP-Autodesk, Coca-Cola, NetApp

Reuters
·
28 Feb

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis

PR Newswire
·
28 Feb

BRIEF-Altimmune Files For Mixed Shelf Offering Of Up To $400 Million- SEC Filing

Reuters
·
28 Feb

Altimmune files $400M mixed securities shelf

TIPRANKS
·
28 Feb